BW373U86, a δ opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation

被引:60
|
作者
Patel, HH [1 ]
Hsu, A [1 ]
Moore, J [1 ]
Gross, GJ [1 ]
机构
[1] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA
关键词
free radicals; opioids; delayed protection; 2-MPG;
D O I
10.1006/jmcc.2001.1408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
H. H. PATEL, A. HSU, J. MOORE AND G. J. GROSS, BW373US86, a delta Opioid Agonist, Partially Mediates Delayed Cardioprotection via a Free Radical Mechanism that is Independent of Opioid Receptor Stimulation. Journal of Molecular and Cellular Cardiology (2001) 33, 1455-1465, Opioids have been shown to produce both an early and delayed phase of cardioprotection; however, the signaling pathways involved, particularly in the delayed response, have not been well defined, Therefore, we investigated the potential of BM373U86 (BW), a potent delta opioid agonist, to produce delayed cardioprotection and characterized the role of opioid receptors and oxygen-derived free radicals (OFRs) in this delayed response, All rats underwent 30 min of ischemia followed by 2 h of reperfusion. The rats were divided into four groups. First, rats were pretreated with selective opioid receptor antagonists or the antioxidant, 2-mercaptopropionyl glycine (2-MPG), in the presence of BW and allowed to recover for 24h before the ischemia-reperfusion protocol. Second, rats were pretreated with BW, allowed to recover for 24 h, and subsequently treated with either opioid antagonists or 2-MPG, 10 min prior to the ischemia-reperfusion protocol. Third, rats underwent ischemic preconditioning (TPC) (1 x 5 min occlusion) both with and without 2-MPG to determine the role of OFRs in acute cardioprotection. Fourth, rats were pretreated with TAN-67, an opioid agonist known to signal through the delta (1) opioid receptor in the presence and absence of 2-MPG. Control rats were injected with saline and allowed to recover for 24 h. BW produced a bell-shaped dose-related reduction in infarct size with a maximal reduction observed at 0.1 mg/kg v control (16 +/- 3% v 60 +/- 3%, P < 0.001). Surprisingly the delayed protect-ion induced by BW was only partially blocked by pretreatment with the delta (1)-selective antagonist, BNTX: however, it was completely blocked by pretreatment with 2-MPG (47 +/- 5%. P < 0.001). Only naloxone given acutely inhibited the protective effects of BW; however, at the dose used, 2-MPG partially reduced the protective effect of acute IPC, TAN-67 (0.1 mg/kg) also produced a significant reduction in infarct size compared to control (18 +/- 4% v 60 +/- 3%, P < 0.001). This protection was blocked by pretreatment with 2-MPG (42 +/- 4%, P < 0.001). These data suggest that BW and TAN-67 mediate delayed cardioprotection via a free radical mechanism that appears to be only partially dependent on delta opioid receptor stimulation. Furthermore, it is the early burst in OFRs that is crucial to initiating the protective effect.
引用
收藏
页码:1455 / 1465
页数:11
相关论文
共 34 条
  • [1] The δ-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats
    Torregrossa, MM
    Isgor, C
    Folk, JE
    Rice, KC
    Watson, SJ
    Woods, JH
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (04) : 649 - 659
  • [2] The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats
    Mary M Torregrossa
    Ceylan Isgor
    John E Folk
    Kenner C Rice
    Stanley J Watson
    James H Woods
    Neuropsychopharmacology, 2004, 29 : 649 - 659
  • [3] A NOVEL, POTENT AND SELECTIVE NONPEPTIDIC DELTA-OPIOID RECEPTOR AGONIST BW373U86
    CHANG, KJ
    RIGDON, GC
    HOWARD, JL
    MCNUTT, RW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 267 (02): : 852 - 857
  • [4] AN EFFICIENT SYNTHESIS OF THE BENZHYDRYLPIPERAZINE DELTA-OPIOID AGONIST (+)-BW373U86
    BISHOP, MJ
    MCNUTT, RW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (12) : 1311 - 1314
  • [5] Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice
    ONeill, SJ
    Collins, MA
    Pettit, HO
    McNutt, RW
    Chang, KJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (01): : 271 - 277
  • [6] Non-peptide δ opioid agonists mediate delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation
    Patel, HH
    Hsu, AK
    Moore, J
    Gross, GJ
    CIRCULATION, 2001, 104 (17) : 59 - 59
  • [7] CONVULSIVE EFFECTS OF SYSTEMIC ADMINISTRATION OF THE DELTA-OPIOID AGONIST BW373U86 IN MICE
    COMER, SD
    HOENICKE, EM
    SABLE, AI
    MCNUTT, RW
    CHANG, KJ
    DECOSTA, BR
    MOSBERG, HI
    WOODS, JH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 267 (02): : 888 - 895
  • [8] BW373U86, A NONPEPTIDE DELTA-OPIOID AGONIST WITH NOVEL RECEPTOR-PROTEIN-MEDIATED ACTIONS
    SELLEY, DE
    CHILDERS, SR
    CHANG, KJ
    REGULATORY PEPTIDES, 1994, : S27 - S28
  • [10] Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats
    Sezen, SF
    Kenigs, VA
    Kapusta, DR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 287 (01): : 238 - 245